Dr. Jame Abraham

Dr. Jame Abraham, a leading medical oncologist specializing in breast cancer at the Cleveland Clinic, shares groundbreaking insights from the SABCS 2024. He discusses the EUROPA trial, revealing the impact of treatment choices for patients over 70. The conversation dives into the TAILORx updates, highlighting anthracycline benefits for high-risk younger patients. Dr. Abraham also explores the PADMA study, affirming the role of CDK4/6 inhibitors, and the promising EMBER-3 results with new oral drugs for advanced cases. A must-listen for cancer treatment innovations!